0000880771-17-000108.txt : 20170614
0000880771-17-000108.hdr.sgml : 20170614
20170614165029
ACCESSION NUMBER: 0000880771-17-000108
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170612
FILED AS OF DATE: 20170614
DATE AS OF CHANGE: 20170614
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: SCICLONE PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0000880771
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 943116852
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 950 TOWER LANE
STREET 2: SUITE 900
CITY: FOSTER CITY
STATE: CA
ZIP: 94404-2125
BUSINESS PHONE: 650-358-3456
MAIL ADDRESS:
STREET 1: 950 TOWER LANE
STREET 2: SUITE 900
CITY: FOSTER CITY
STATE: CA
ZIP: 94404-2125
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Xie Lan
CENTRAL INDEX KEY: 0001555794
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19825
FILM NUMBER: 17911633
MAIL ADDRESS:
STREET 1: 29F SHANGHAI TIMES SQUARE
STREET 2: NO. 93 HUAI HAI ZHONG ROAD
CITY: SHANGHAI
STATE: F4
ZIP: 200021
4
1
certent-form4.xml
PRIMARY DOCUMENT
X0306
4
2017-06-12
0000880771
SCICLONE PHARMACEUTICALS INC
SCLN
0001555794
Xie Lan
950 TOWER LANE, SUITE 900
FOSTER CITY
CA
94404
0
1
0
0
VP Finance, China CFO
Common Stock
2017-06-12
4
M
0
1000
0
A
1000
D
Common Stock
2017-06-12
4
S
0
1000
10.75
D
0
D
Restricted Stock Unit
2017-06-12
4
M
0
1000
0
D
Common Stock
1000
18000
D
Granted under the Issuer's 2005 Equity Incentive Plan.
Each restricted stock unit represents the right to receive, at settlement, one share of common stock.
Vesting for such RSUs will occur 25% on March 16, 2016, 25% on March 16, 2017, 25% on March 16, 2018, and 25% on March 16, 2019, or on such later date thereafter as the Company's trading window opens, if it is not open on any of such dates, contingent upon the executive's continued employment.
/s/ Wilson W. Cheung, Attorney-in-Fact For: Lan Xie
2017-06-14